| Description | HPCG is an inhibitor of HIF-1α prolyl hydroxylase. |
| molecular weight | 196.16 |
| Molecular formula | C8H8N2O4 |
| CAS | 3458-69-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| References | 1. Gun'ko VM, Turov VV, Zarko VI, Goncharuk OV, Pakhlov EM, Skubiszewska-Zięba J, Blitz JP. Interfacial phenomena at a surface of individual and complex fumed nanooxides. Adv Colloid Interface Sci. 2016 Sep;235:108-189. doi: 10.1016/j.cis.2016.06.003. Epub 2016 Jun 11. Review. PubMed PMID: 27344189. 2. Mozaffary A, Asgari S, Tohidi M, Kazempour-Ardebili S, Azizi F, Hadaegh F. Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study. BMJ Open. 2016 May 23;6(5):e010889. doi: 10.1136/bmjopen-2015-010889. PubMed PMID: 27217283; PubMed Central PMCID: PMC4885425. 3. Watanabe T, Miyao M, Honda R, Yamada Y. Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers. Environ Health Prev Med. 2008 Sep;13(5):264-70. doi: 10.1007/s12199-008-0039-8. Epub 2008 Jul 5. Erratum in: Environ Health Prev Med. 2009 May;14(3):209. PubMed PMID: 19568913; PubMed Central PMCID: PMC2698250. 4. Ayres CG, Griffith HM. Consensus guidelines: improving the delivery of clinical preventive services. Health Care Manage Rev. 2008 Oct-Dec;33(4):300-7. doi: 10.1097/01.HCM.0000318767.36901.0b. PubMed PMID: 18815495. |